Sanofi has shared positive results from a late-stage study of its investigational BTK inhibitor, tolebrutinib, in patients ...
Ipsen’s Iqirvo (elafibranor) has been conditionally approved by the European Commission (EC) to treat primary biliary ...
Rybrevant (amivantamab-vmjw) has been approved by the US Food and Drug Administration (FDA) as part of a combination ...
It was very disconcerting. For a fraction of a second, as I sat in a plush, modern boardroom, there across the table from me sat a magnificent giraffe, slowly ruminating as its small horns and large ...
Direct Express is a well-established company based to the north of London – at Welham Green, Hertfordshire – which is close to the M25, M4, M3, M1 and A1(M).
We are 20:20 Selection. Over more than 10 years we have built our reputation in providing unrivalled professional medical recruitment services to both our clients and candidates. During that time we ...
3DforScience is a Scientific communication and medical animation company for the healthcare sector focused on helping pharmaceutical, biotechnology and healthcare companies for marketing actions ...
PPi specialises in providing guidance and implementation services for healthcare provision. PPi supports the development of market access strategies as well as the ultimate implementation of such ...
Akceso Advisors AG Akceso is a specialist pricing, reimbursement & market access consultancy providing innovative tools to optimise opportunities. Headquartered in Basel, Switzerland, Akceso is ...
C4H Solutions C4H Solutions can support the work you are doing and give you a real boost to your plans by utilising our range of NHS Engagement and Market Intelligence Solutions. This is a FREE ...
IMARC is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value ...
CD BioScinces provides clinical trial services including bioanalytical lab testing, clinical pharmacology, first-in-human (FIH), proof of concept (POC), early phase trials, phase IIa trials, phase IIb ...